Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment [PDF]
Robert M Pascuzzi, Cynthia L Bodkin Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, USACorrespondence: Robert M Pascuzzi, Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, 46202, USA ...
Robert M Pascuzzi
exaly +4 more sources
Late onset cerebellar ataxia syndrome after non-paraneoplastic Lambert-Eaton myasthenic syndrome: a case study. [PDF]
This is an unusual case of voltage gated calcium channel (VGCC) antibodies leading to two distinct and chronologically separated neurologic syndromes without the presence of an underlying neoplasm.
Randall DP, Randall MC.
europepmc +3 more sources
Lambert-Eaton myasthenic syndrome with primary thymic marginal zone B-cell lymphoma: A case report. [PDF]
Lambert‐Eaton myasthenic syndrome (LEMS) is an autoimmune paraneoplastic syndrome with proximal muscle weakness, that often complicates small cell lung cancer.
Soma T +3 more
europepmc +2 more sources
Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan. [PDF]
Background There was no nationwide epidemiological study of Lambert-Eaton myasthenic syndrome (LEMS) in Japan; therefore, we conducted a nationwide survey.Methods For the first survey, we sent survey sheets to randomly selected medical departments (n ...
Yoshikawa H +10 more
europepmc +2 more sources
Spontaneous regression of small cell lung cancer associated with Lambert-Eaton Myasthenic Syndrome: Case report. [PDF]
Spontaneous regression (SR) of cancer is very rare, especially of small cell lung cancer (SCLC). Recently, an association of paraneoplastic neurological syndrome (PNS) has been reported as a cause of SR of cancer, and onconeural antibodies are a possible
Otani M +17 more
europepmc +2 more sources
Lambert-Eaton myasthenic syndrome presenting with occult mediastinal small cell carcinoma and positivity for anti-CV2/CRMP5 and anti-SOX1 antibodies: a case report. [PDF]
Background Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune neuromuscular disorder characterized by proximal muscle weakness, autonomic dysfunction and hyporeflexia.
Wang A, Li H, Li D, Wang K, Zhang L.
europepmc +2 more sources
The Case of a 28‐Year‐Old Man With Gradually Progressive Proximal Leg Weakness
This is a case of a 28‐year‐old man who presented with a 6‐month history of gradually progressive proximal leg weakness and pain that worsened on exercise and was relieved by rest. He had no symptoms in his upper limbs.
Melody T. Asukile +3 more
doaj +2 more sources
Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome. [PDF]
Lambert-Eaton myasthenic syndrome (LEMS) is a rare disease but is often associated with small-cell lung cancer (SCLC). We discuss the case of a 65-year-old man diagnosed with SCLC-LEMS and treated with carboplatin, etoposide, and durvalumab.
Ishibashi N +7 more
europepmc +2 more sources
SOX-1 antibodies positive Lambert-Eaton myasthenic syndrome with occult small cell lung cancer: A case report. [PDF]
Lambert–Eaton myasthenic syndrome (LEMS) is a rare paraneoplastic neurological syndrome of the neuromuscular transmission. The symptoms often progress slowly and can be misdiagnosed in early stage.
Zhao L +5 more
europepmc +2 more sources
Atypical Presentation of Seronegative Paraneoplastic Lambert-Eaton Myasthenic Syndrome with Cerebellar Ataxia. [PDF]
Rohatgi S +9 more
europepmc +2 more sources

